SIDETRADE (ALBFR.PA) Fundamental Analysis & Valuation

EPA:ALBFR • FR0010202606

Current stock price

154 EUR
-2.8 (-1.79%)
Last:

This ALBFR.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. ALBFR.PA Profitability Analysis

1.1 Basic Checks

  • ALBFR had positive earnings in the past year.
  • ALBFR had a positive operating cash flow in the past year.
  • ALBFR had positive earnings in each of the past 5 years.
  • Each year in the past 5 years ALBFR had a positive operating cash flow.
ALBFR.PA Yearly Net Income VS EBIT VS OCF VS FCFALBFR.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 9.46%, ALBFR is in the better half of the industry, outperforming 76.23% of the companies in the same industry.
  • ALBFR's Return On Equity of 19.66% is fine compared to the rest of the industry. ALBFR outperforms 75.41% of its industry peers.
  • ALBFR has a better Return On Invested Capital (9.28%) than 68.03% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ALBFR is below the industry average of 13.21%.
  • The 3 year average ROIC (8.57%) for ALBFR is below the current ROIC(9.28%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.46%
ROE 19.66%
ROIC 9.28%
ROA(3y)8.09%
ROA(5y)8.31%
ROE(3y)16.87%
ROE(5y)17.25%
ROIC(3y)8.57%
ROIC(5y)9.37%
ALBFR.PA Yearly ROA, ROE, ROICALBFR.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • The Profit Margin of ALBFR (14.17%) is better than 70.49% of its industry peers.
  • ALBFR's Profit Margin has improved in the last couple of years.
  • ALBFR has a Operating Margin of 10.85%. This is in the better half of the industry: ALBFR outperforms 60.66% of its industry peers.
  • ALBFR's Operating Margin has improved in the last couple of years.
  • With a Gross Margin value of 75.88%, ALBFR perfoms like the industry average, outperforming 54.10% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ALBFR has grown nicely.
Industry RankSector Rank
OM 10.85%
PM (TTM) 14.17%
GM 75.88%
OM growth 3Y-11.7%
OM growth 5Y3.49%
PM growth 3Y-0.3%
PM growth 5Y10.94%
GM growth 3Y2.02%
GM growth 5Y2.88%
ALBFR.PA Yearly Profit, Operating, Gross MarginsALBFR.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. ALBFR.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ALBFR is still creating some value.
  • ALBFR has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ALBFR has been increased compared to 5 years ago.
  • Compared to 1 year ago, ALBFR has an improved debt to assets ratio.
ALBFR.PA Yearly Shares OutstandingALBFR.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M
ALBFR.PA Yearly Total Debt VS Total AssetsALBFR.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • ALBFR has an Altman-Z score of 4.82. This indicates that ALBFR is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.82, ALBFR is in the better half of the industry, outperforming 73.77% of the companies in the same industry.
  • ALBFR has a debt to FCF ratio of 1.10. This is a very positive value and a sign of high solvency as it would only need 1.10 years to pay back of all of its debts.
  • ALBFR has a better Debt to FCF ratio (1.10) than 66.39% of its industry peers.
  • ALBFR has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
  • ALBFR has a better Debt to Equity ratio (0.16) than 65.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 1.1
Altman-Z 4.82
ROIC/WACC1.16
WACC7.99%
ALBFR.PA Yearly LT Debt VS Equity VS FCFALBFR.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

  • ALBFR has a Current Ratio of 1.47. This is a normal value and indicates that ALBFR is financially healthy and should not expect problems in meeting its short term obligations.
  • ALBFR has a Current ratio (1.47) which is in line with its industry peers.
  • ALBFR has a Quick Ratio of 1.47. This is a normal value and indicates that ALBFR is financially healthy and should not expect problems in meeting its short term obligations.
  • ALBFR has a Quick ratio (1.47) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 1.47
ALBFR.PA Yearly Current Assets VS Current LiabilitesALBFR.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. ALBFR.PA Growth Analysis

3.1 Past

  • ALBFR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.87%, which is quite good.
  • ALBFR shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 27.85% yearly.
  • Looking at the last year, ALBFR shows a very strong growth in Revenue. The Revenue has grown by 24.74%.
  • The Revenue has been growing by 16.43% on average over the past years. This is quite good.
EPS 1Y (TTM)17.87%
EPS 3Y16.56%
EPS 5Y27.85%
EPS Q2Q%13.63%
Revenue 1Y (TTM)24.74%
Revenue growth 3Y19.06%
Revenue growth 5Y16.43%
Sales Q2Q%18.08%

3.2 Future

  • The Earnings Per Share is expected to grow by 12.71% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 13.39% on average over the next years. This is quite good.
EPS Next Y22.07%
EPS Next 2Y9.61%
EPS Next 3Y12.71%
EPS Next 5YN/A
Revenue Next Year11.68%
Revenue Next 2Y14.27%
Revenue Next 3Y13.39%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ALBFR.PA Yearly Revenue VS EstimatesALBFR.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M
ALBFR.PA Yearly EPS VS EstimatesALBFR.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

4

4. ALBFR.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 27.75 indicates a quite expensive valuation of ALBFR.
  • Compared to the rest of the industry, the Price/Earnings ratio of ALBFR indicates a somewhat cheap valuation: ALBFR is cheaper than 61.48% of the companies listed in the same industry.
  • ALBFR is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.87, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 23.88, which indicates a rather expensive current valuation of ALBFR.
  • ALBFR's Price/Forward Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 38.51, ALBFR is valued a bit cheaper.
Industry RankSector Rank
PE 27.75
Fwd PE 23.88
ALBFR.PA Price Earnings VS Forward Price EarningsALBFR.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • ALBFR's Enterprise Value to EBITDA ratio is in line with the industry average.
  • ALBFR's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 37.53
EV/EBITDA 27.38
ALBFR.PA Per share dataALBFR.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • ALBFR's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of ALBFR may justify a higher PE ratio.
  • A more expensive valuation may be justified as ALBFR's earnings are expected to grow with 12.71% in the coming years.
PEG (NY)1.26
PEG (5Y)1
EPS Next 2Y9.61%
EPS Next 3Y12.71%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALBFR.PA Dividend Analysis

5.1 Amount

  • ALBFR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALBFR.PA Fundamentals: All Metrics, Ratios and Statistics

SIDETRADE

EPA:ALBFR (4/17/2026, 7:00:00 PM)

154

-2.8 (-1.79%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)04-14
Earnings (Next)07-21
Inst Owners18.64%
Inst Owner ChangeN/A
Ins Owners35.29%
Ins Owner ChangeN/A
Market Cap231.00M
Revenue(TTM)59.46M
Net Income(TTM)8.43M
Analysts84
Price Target198.9 (29.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-32.76%
PT rev (3m)-31.58%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)11.38%
EPS NY rev (3m)8.72%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.97%
Valuation
Industry RankSector Rank
PE 27.75
Fwd PE 23.88
P/S 3.88
P/FCF 37.53
P/OCF 32.65
P/B 5.39
P/tB 19.35
EV/EBITDA 27.38
EPS(TTM)5.55
EY3.6%
EPS(NY)6.45
Fwd EY4.19%
FCF(TTM)4.1
FCFY2.66%
OCF(TTM)4.72
OCFY3.06%
SpS39.64
BVpS28.58
TBVpS7.96
PEG (NY)1.26
PEG (5Y)1
Graham Number59.7392 (-61.21%)
Profitability
Industry RankSector Rank
ROA 9.46%
ROE 19.66%
ROCE 12.63%
ROIC 9.28%
ROICexc 19.81%
ROICexgc N/A
OM 10.85%
PM (TTM) 14.17%
GM 75.88%
FCFM 10.35%
ROA(3y)8.09%
ROA(5y)8.31%
ROE(3y)16.87%
ROE(5y)17.25%
ROIC(3y)8.57%
ROIC(5y)9.37%
ROICexc(3y)18.44%
ROICexc(5y)20.75%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)11.66%
ROCE(5y)12.74%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-1.75%
ROICexc growth 5Y5.4%
OM growth 3Y-11.7%
OM growth 5Y3.49%
PM growth 3Y-0.3%
PM growth 5Y10.94%
GM growth 3Y2.02%
GM growth 5Y2.88%
F-Score6
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 1.1
Debt/EBITDA 0.88
Cap/Depr 74.39%
Cap/Sales 1.55%
Interest Coverage 250
Cash Conversion 91.99%
Profit Quality 73.03%
Current Ratio 1.47
Quick Ratio 1.47
Altman-Z 4.82
F-Score6
WACC7.99%
ROIC/WACC1.16
Cap/Depr(3y)191.5%
Cap/Depr(5y)202.1%
Cap/Sales(3y)4.08%
Cap/Sales(5y)4.13%
Profit Quality(3y)97.77%
Profit Quality(5y)121.95%
High Growth Momentum
Growth
EPS 1Y (TTM)17.87%
EPS 3Y16.56%
EPS 5Y27.85%
EPS Q2Q%13.63%
EPS Next Y22.07%
EPS Next 2Y9.61%
EPS Next 3Y12.71%
EPS Next 5YN/A
Revenue 1Y (TTM)24.74%
Revenue growth 3Y19.06%
Revenue growth 5Y16.43%
Sales Q2Q%18.08%
Revenue Next Year11.68%
Revenue Next 2Y14.27%
Revenue Next 3Y13.39%
Revenue Next 5YN/A
EBIT growth 1Y16.13%
EBIT growth 3Y5.13%
EBIT growth 5Y20.49%
EBIT Next Year28.13%
EBIT Next 3Y16.96%
EBIT Next 5YN/A
FCF growth 1Y158.61%
FCF growth 3Y12.94%
FCF growth 5Y37.14%
OCF growth 1Y100%
OCF growth 3Y9.02%
OCF growth 5Y29.8%

SIDETRADE / ALBFR.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of SIDETRADE (ALBFR.PA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to ALBFR.PA.


What is the valuation status of SIDETRADE (ALBFR.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to SIDETRADE (ALBFR.PA). This can be considered as Fairly Valued.


What is the profitability of ALBFR stock?

SIDETRADE (ALBFR.PA) has a profitability rating of 7 / 10.


What are the PE and PB ratios of SIDETRADE (ALBFR.PA) stock?

The Price/Earnings (PE) ratio for SIDETRADE (ALBFR.PA) is 27.75 and the Price/Book (PB) ratio is 5.39.


How sustainable is the dividend of SIDETRADE (ALBFR.PA) stock?

The dividend rating of SIDETRADE (ALBFR.PA) is 0 / 10 and the dividend payout ratio is 0%.